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This study investigated proteomic changes occurring in Anopheles
gambiae and Anopheles stephensi during adult mosquito aging. These
changes were evaluated using two-dimensional difference gel
electrophoresis (2D-DIGE) and the identities of aging related proteins
were determined using capillary high-pressure liquid chromatography
(capHPLC) coupled with a linear ion-trap (LTQ)-Orbitrap XL hybrid
mass spectrometry (MS). Here, we have described the techniques used
to determine age associated proteomic changes occurring in heads and
thoraces across three age groups; 1, 9 and 17 d old A. gambiae and
4 age groups; 1, 9, 17 and 34 d old A. stephensi. We have provided
normalised spot volume raw data for all protein spots that were visible
on 2D-DIGE images for both species and processed Orbitrap mass
spectrometry data. For public access, mass spectrometry raw data are
available via ProteomeXchange with identiﬁer PXD002153. A detailed
description of this study has been described elsewhere [1].
& 2015 The Authors. Published by Elsevier Inc. This is an open access
article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
/j.jprot.2015.06.008
du.au (M.T. Sikulu).
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More speciﬁc
subject areaProtein analysis, MSType of data Images, tables
How data was
acquired2D-DIGEData format Typhoon 9000 and 94,000 images, raw and analysed
Experimental factors Changes in protein abundance was evaluated at 1,9 and 17 d of age for A. gambiae and at 1, 9, 17 and
34 d for A. stephensi
Experimental
featuresExploratory data for establishing age related biomarkers of malaria vectorsData source location QIMR Berghofer Medical Research Institute, Brisbane, Australia, Ifakara Health Institute, Tanzania
Data accessibility LTQ-Orbitrap XL hybrid MS processed data is within this article but raw MALDI-TOF/TOF and LTQ-
Orbitrap XL hybrid MS data is available in a public repository via ProteomeXchange with identiﬁer
PXD002153Value of the data This study investigated the changes that occur in the head and thorax proteome of two major
malaria vectors; the African and Asian malaria vectors, A. gambiae and A. stephensi respectively,
during adult aging. These changes may highlight underlying mechanisms of the relationship between mosquito age
and factors affecting Plasmodium transmission and mosquito control. A future study could use these data to identify robust age biomarkers to be incorporated into rapid
age detection assays such as ELISA or dipstick assays applicable as surveillance tools in vector
control settings.1. Experimental design, materials and methods
1.1. Mosquito preparation and protein extraction
Two cohorts each of A. gambiae and A. stephensi were reared at different times. For each cohort,
adults were collected 24 h post emergence and again at 9 and 17 d post emergence for A. gambiae and
at 9, 17 and 34 d post emergence for A. stephensi. Heads and thoraces of ﬁve females at 1, 9 and 17 d of
age for A. gambiae and 1, 9, 17 and 34 d for A. stephensi were dissected on a bed of dry ice and pooled
into 2 ml plastic screw-cap vials containing 90 ml of 2D buffer (7 M Urea, 2 M Thiourea and 4% [w/v]
CHAPS), 1dissolved PhosSTOP (Roche, Penzerb, upper Bavaria, Germany) and two 3 mm silica glass
beads. Proteins were extracted by homogenising samples using a Minibead-beater 96 (BioSpec
Products, Inc. Bartlesville, OK, USA) for 1.45 min. The contents were collected by brief centrifugation at
12,000 g. The sample was transferred to new 1.5 ml micro-centrifuge tubes and clariﬁed by
centrifuging twice at 21,000 g for 10 min. Protein was puriﬁed using the 2D clean-up kit (GE
Healthcare, Waukesha, WI, USA.) according to the manufacturer's protocol. Samples were then
resuspended in 2D buffer and total protein content was quantiﬁed using the 2D quantiﬁcation kit (GE
Healthcare) following the manufacturer's protocol. Fifty micrograms of protein was prepared in a 2D
buffer for each age sample. An internal standard sample was prepared by combining 25 mg of protein
from each age sample into a single pool. The pH of all the samples was adjusted to between 8 and 9.1.
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included at each age and the entire experiment was replicated a second time using the second cohort
of mosquitoes.
1.2. 2D-DIGE
Experiments with 2D-DIGE followed the procedures described by Hugo and colleagues [2]. The
Stock solutions of each of Cy2, Cy3 and Cy5 ﬂuorescent cyanine dyes (GE Healthcare) was prepared by
reconstituting the appropriate dye in 5 ml Dimethylformamide (Sigma Chemical Co. Ltd., St Louis, MO,
USA.) to a concentration of 1 nM. Four hundred picomoles of either Cy3 or Cy5 was added to each
sample and 2400 pmol of Cy2 was added to the internal standard. Each sample pool was combined
with 4.5 ml of 100 ampholytes (Bio-Rad, Richmond, CA, USA.), 5.6 ml Destreak reagent (GE
Healthcare) and made up to 450 ml in 2D Buffer. Samples were loaded onto 24 cm, pH 3–10
immobilised pH gradient strips (Bio-Rad) in rehydration trays and left at room temperature for 4 h for
the strips to absorb the sample. Following absorption, the strips were transferred to a new focussing
tray, overlayed with mineral oil and allowed to rehydrate overnight at room temperature. For ﬁrst
dimension separation, the strips were transferred to a dry protean iso-electric focusing tray. The strips
were overlayed with fresh mineral oil and iso-electric focussing was performed using the following
run conditions: 50 μA per strip, 250 V for 15 min, 1000 V for 5 h, 10,000 V for 4 h and 500 V to reach a
total of 80,000 V h1. Focus strips were equilibrated for 15 min in buffer I containing 6 M Urea,
0.375 M Tris–HCl pH 8.8, 2% [w/v] SDS, 20% [v/v] glycerol and 2% [w/v] DTT and then for 15 min in
buffer II containing 6 M Urea, 0.375 M Tris–HCl, 2% [w/v] SDS, 20% [v/v] glycerol and 2.5% [w/v]
Iodoacetamide. The strips were placed on 12% acrylamide gels cast in 24 cm optically clear plates.
Electrophoresis was performed in a Proteans Plus Dodeca cell (Bio-Rad) at 5 mA/gel for 15 min,
10 mA/gel for 15 min and 30 mA/gel until the dye front reached the bottom of the gel.
1.3. Imaging and processing
A. stephensi gels were scanned using a Typhoon FLA-9400 ﬂuorescent imager (GE Healthcare) at
100 mm pixel resolution, using the 520 band pass (BP) 40 ﬁlter for Cy2, 580 BP 30 ﬁlter for Cy3 and the
670 BP 30 ﬁlter for Cy5 emission. A. gambiae gels were scanned using a FLA-9000 Starion ﬂuorescent
imager (GE Healthcare) at 100 mm pixel resolution using the BPB1 (530DF20) ﬁlter for Cy2, DGR1
(570DF20/665LP) ﬁlter for Cy3 and LPR (665LP) ﬁlter for Cy5. Fluorescent images were processed and
analysed using Delta2D version 4.0 software (Decodon, Greifswald, Germany). Spots on gel images
scanned from the same gel were then connected by direct warping and the spots on all gels were
aligned and normalised for intensity using the Cy2 channel (Internal standard images) on each gel
with the match vectors tool. All aligned images were fused and thereafter spot validations were
transferred to all other images from this fused image [3]. All spots that were visible on 2D-DIGE
images for both species are shown in Supplementary tables 1–4.
1.4. Sample preparation for MS
Protein spots for identiﬁcation were manually excised from 2D gels using the method of Hugo and
colleagues [2]. The gels were stained with colloidal Coomassie 0.12% [w/v] brilliant blue G250 stain
(Sigma Chemical Co., Ltd.), 10% [w/v] NH4SO4, 10% [v/v] phosphoric acid and 20% [v/v] methanol in
distilled water. The differentially expressed spots were excised from these gels using a glass plug
cutter and destained overnight in 300 ml of MS ﬁx solution containing 40% [v/v] ethanol and 10% [v/v]
acetic acid. The solution was discarded and 100 ml of 25 mM ammonium bicarbonate (Sigma Chemical
Co., Ltd.), pH 8, was added and the samples were placed on an orbital shaker at room temperature for
15 min. The solution was discarded and the ammonium bicarbonate wash was repeated twice more.
Gel plugs were dried in a vacuum concentrator for 30 min. The gels were rehydrated in 4 ml of 1 mg/ml
proteomics grade trypsin (Sigma Chemical Co., Ltd.) in 40 mM ammonium bicarbonate containing 10%
[v/v] acetonitrile (ACN) and incubated for 1 h at room temperature. A further 35 ml of 40 mM
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at 37 1C. Tryptic extracts bathing the plugs from equivalent spot samples were pooled into a single
tube. 20 ml of 50% [v/v] ACN containing 0.1% [v/v] Triﬂouroacetic acid (TFA) (Sigma Chemical Co., Ltd.)
was added to the gel plugs and incubated at room temperature, shaking for 1 h. The solution bathing
the gels was combined with the previous extracts. Pooled extracts were lyophilised, rehydrated in
30 μl of 0.1% [v/v] TFA and concentrated using C18 Zip-Tips (Millipore, Billerica, MA, USA.) according to
the manufacturer's instructions. In-gel tryptic digests were analysed by either MALDI-TOF/TOF MS [4]
or separated by CapHPLC and sprayed directly into the ion source of LTQ-Orbitrap XL hybrid MS [5].
1.5. MALDI-TOF/TOF analysis
All mass spectra from the in-gel tryptic digests were acquired in positive ion mode on an Ultraﬂex
III MALDI-TOF/TOF MS (Bruker Daltonik GmbH, Bremen, Germany). Reﬂectron mode was used to
measure the spectra with typical resolution within the range of 15,000 and 20,000. Mass accuracies of
within 50 ppm for MS measurements and between 60 and 250 ppm for tandem MS (MS/MS)
measurements were obtained. Saturated α-Cyano-4-hydroxy cinnamic acid (α-CHCA) matrix was
prepared in 97% [v/v] acetone containing 0.3 mM ammonium dihydrogen phosphate and 0.1% [v/v]
TFA, subsequently diluted 15 times in 6:3:1 ethanol:acetone:10 mM ammonium dihydrogen
phosphate and 0.1% [v/v] TFA. This was used as matrix for all MS and MS/MS analyses at a sample
to matrix ratio of 1:2. MS/MS spectra were automatically acquired with 40% higher laser intensity than
that used for MS analysis. Spectra were calibrated using a peptide calibration standard mixture
(Bruker Daltonics. Kit number 208241) of nine peptides in the mass range of m/z¼1046 and m/
z¼3147, with 62.5 fmol of each peptide applied to calibration spots. High precision MS/MS calibration
was achieved using fragment ions derived from all the nine peptides in the MS calibration kit and the
associated calibration coefﬁcients were applied to the method ﬁle used to acquire MS/MS data. The
data were automatically acquired and processed in a batch mode by Bruker Daltonics Flex-series
software (FlexControl and FlexAnalysis version 2.4), and searched using MASCOT search engine with a
custom made database using Bio-tools version 3.1. Instrument settings for MS were: ion source
1 potential, 25.00 kV; ion source 2 potential, 21.70 kV; reﬂectron 1 potential, 26.30 kV; reﬂectron
2 potential, 13.85 kV and for MS/MS were: ion source 1 potential, 8.00 kV; ion source 2 potential,
7.20 kV; reﬂectron 1 potential, 29.50 kV; reﬂectron 2 potential, 13.75 kV; LIFT 1 voltage, 19.00 kV; LIFT
2 voltage, 3.00 kV. Ion selector resolution was set at 0.5% of the mass of the precursor ion [6]. All
protein spots identiﬁed by MALDI-TOF/TOF mass spectrometry are reported in our accompanying
manuscript [1].
1.6. Liquid chromatography (LC)–MS/MS analysis
In-gel tryptic digests were fractionated by CapHPLC using a Shimadzu Prominence HPLC system
(Shimadzu) and were introduced directly into the LTQ-Orbitrap XL hybrid MS (Thermo Fisher
Scientiﬁc, Bremen, Germany) equipped with a dynamic nanoelectrospray ion source (Proxeon,
Odense, Denmark) and distal coated silica emitters (30 μm i.d., 20 μm tip i.d; New Objective, Woburn,
MA, USA.). Acidiﬁed samples were loaded onto a 120 Å, 3 μm particle size, 300 μm by10 mm C18-AQ
Reprosil-Pur trap column (SGE Australia Pty., Ltd.) at 30 μl/min in 98% solvent A (0.1% [v/v] aqueous
formic acid) and 2% solvent B (80% [v/v] acetonitrile containing 0.1% [v/v] formic acid) for 3 min at
40 1C, and were subsequently gradient eluted onto a pre-equilibrated self-packed analytical column
(Dr. Maisch GmbH Reprosil-Pur C18-AQ, 120 Å, 150 μm by 200 mm) using a ﬂow rate of 900 nl/min.
The LTQ-Orbitrap was controlled using Xcalibur 2.0 SR1 (Thermo Fisher Scientiﬁc). Analyses were
carried out in data-dependent acquisition mode, whereby the survey full scan mass spectra (m/z 300–
2000) were acquired in the Orbitrap FT mass analyser at a resolution of 60,000 (at 400m/z) after
accumulating ions to an automatic gain control target value of 5.0105 charges in the LTQ mass
analyser. MS/MS mass spectra were concurrently acquired on the eight most intense ions in the full
scan mass spectra in the LTQ mass analyser to an automatic gain control target value of 3.0104
charges. Charge state ﬁltering, where unassigned precursor ions were not selected for fragmentation,
Fig. 1. Protein spots detected on 2D-DIGE images. Candidate aging biomarker proteins identiﬁed by CapHPLC LTQ-Orbitrap XL
hybrid MS for A. stephensi (Panel A) and A. gambiae (Panel B).
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duration, 90 s) were used. Fragmentation conditions in the LTQ were: 35% normalised collision energy,
activation q of 0.25, isolation width of 3.0 Da, 30 ms activation time, and minimum ion selection
intensity 500 counts. Maximum ion injection times were 500 ms for survey full scans and 100 ms for
MS/MS [3,5–7]. All spots identiﬁed by LC-MS/MS are shown in Fig. 1 and their identities are presented
in Table 1.
1.7. Data analysis
Protein identiﬁcations were performed by searching peptide peak lists detected by TOF/TOF MS
and MS/MS against in-silico databases of theoretical trypsin digests of published proteins using an in-
house MASCOT database search engine (Version 2.2, Matrix Sciences, London) using Biotools version
3.1 (Bruker Daltonics). The LC-MS/MS data were processed and searched against the same database
using an in-house MASCOT database search engine integrated in Proteome Discoverer (version
1.4.0.288, Thermo Fisher Scientiﬁc) software. The database was compiled from UniProtKB database onTable 1
Identities of age associated A. stephensi and A. gambiae spots shown in Fig. 1. Identities were determined using CapHPLC LTQ-
Orbitrap XL hybrid MS/MS and MASCOT database searching.
Spot Protein name Score Coverage No. of
Proteins
No. of
Unique
peptides
No. of
PSMs
No.
of
AA
Mw
[kDa]
Calc.
pI
641a ASTEI05637-PA hypothetical protein 950.92 68.02 1 13 68 172 19.5 5.95
ASTEI06099-PA hypothetical protein 311.69 33.90 1 8 35 177 20.4 5.91
ASTEI09076-PA hypothetical protein 36.01 14.29 2 2 2 189 21.4 5.73
707a ASTE011623-PA hypothetical protein 37.91 14.04 2 2 2 178 19.3 8.18
ASTEI01010-PA hypothetical protein 69.26 27.65 2 4 7 217 23.7 9.20
763a ASTEI10910-PA hypothetical protein 64.46 21.26 1 2 2 127 13.9 6.38
ASTE002628-PA hypothetical protein 52.76 18.25 3 2 3 137 14.3 7.84
774a ASTEI052400-PA hypothetical protein 48.74 21.74 2 2 3 92 10.2 11.18
659a ASTEI05637-PA hypothetical protein 646.94 55.23 1 8 30 172 19.5 5.95
ASTEI09076-PA hypothetical protein 78.65 13.23 2 2 2 189 21.4 5.73
ASTEI06099-PA hypothetical protein 73.27 15.82 1 4 6 177 20.4 5.91
653a ASTEI06860-PA hypothetical protein 387.50 49.50 1 8 38 202 21.8 8.29
501a ASTEI09467-PA hypothetical protein 514.91 29.55 2 2 38 352 38.1 6.95
ASTEI07484-PA hypothetical protein 88.05 16.25 2 4 7 277 31.9 5.86
ASTEI06665-PA hypothetical protein 75.28 10.84 1 3 5 286 30.9 6.99
ASTE001036-PA hypothetical protein 69.42 12.94 2 4 4 309 34.2 6.74
ASTEI00995-PA hypothetical protein 41.85 10.43 2 2 2 163 18.5 8.62
ASTE002048-PA hypothetical protein 41.39 8.85 3 2 2 192 21.9 8.40
ASTE011344-PA hypothetical protein 42.68 6.60 5 2 2 318 34.6 6.54
836a ASTEI01727-PA hypothetical protein 70.13 20.11 2 3 4 184 21.1 4.79
ASTEI05226-PA hypothetical protein 49.86 8.97 3 2 2 223 25.1 6.21
890b AGAP004031-PA Mitochondrial electron
transfer ﬂavour protein subunit alpha
187.85 24.40 2 6 9 332 34.6 8.57
AGAP005627-PC creatine kinase 48.78 7.32 7 2 2 355 39.7 6.47
AGAP009833-PA Voltage-dependent
anion-selective channel protein 2
39.70 8.51 4 2 2 282 30.7 8.56
AGAP008278-PA Long form D7 salivary
protein
31.25 6.11 1 2 3 311 35.6 5.90
AGAP006936-PB Mitochondrial
Cytochrome c1 haem protein
0.00 8.08 4 2 2 297 32.7 8.46
A mass tolerance of 20 ppm for peptide precursor ions was applied in all searches. Multiple protein hits were typically achieved
from spot identiﬁcations using CapHPLC; possibly due to inefﬁcient isoelectric focusing or electrophoresis and/or high
sensitivity of the LTQ-Orbitrap. Therefore, only protein hits with estimated size and charge states within arbitrary ranges
of75 kDa and71 pI from the actual spot positions were included in the table. At least two peptide identiﬁcations were
required to assign protein identiﬁcation.
a A. stephensi proteins pots as shown in Fig. 1A.
b A. gambiae protein spot as shown in Fig. 1B.
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precursor ions and 0.8 Da for fragment ions was applied in all searches except for Orbitrap dataset
where a precursor ion tolerance of 20 ppm was applied. Database search parameters for both MALDI-
TOF/TOF and LTQ-Orbitrap datasets were as follows: enzymatic cleavage, tryptic; ﬁxed modiﬁcations,
S-carboxamidomethylation of cysteine residues; variable modiﬁcations, methionine oxidation,
deamidation of asparagine and glutamine; and missed cleavages. Peptides identiﬁed by TOF/TOF
mass spectrometry were reported as signiﬁcant scoring peptides at a MASCOT probability based score
threshold of po0.05 (o5% chance to be a false positive hit). For the Orbitrap datasets, to estimate the
false discovery rate (FDR) at which the identiﬁcation was considered correct (q-Value), a Percolator
algorithm implemented in Proteome Discoverer (version 1.4.0.288, Thermo Fisher Scientiﬁc) was used
and proteins with peptides having a conﬁdence threshold q-Valueo0.01 (1% FDR) were considered to
be valid. A minimum of two conﬁdent peptide identiﬁcations were required to assign a protein
identity. Putative function of hypothetical proteins was inferred using the VectorBase database.Acknowledgements
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